Amgen raised its outlook for the year after third-quarter profit jumped aided by sixteen products posting at least double-digit sales growth. The Thousand Oaks, Calif.-based biotechnology company on Tuesday reported a profit of $3.22 billion, or $5.93 a share, compared with a profit of $2.83 billion, or $5.22 a share, in the same quarter a year ago. Product sales rose 12%, with 14% volume growth offset by a 4% decline in net selling prices.
Continue Reading
View Comments
Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump
Published 4 days ago
Nov 4, 2025 at 9:33 PM
Positive
Auto